Fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol
Case report
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This case report describes fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia that developed during danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (5)
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
- [Danazol-induced hepatitis with functional deficit of the C1 inhibitor] 2001
- [Spontaneous splenic rupture caused by spleen peliosis in a patient with autoimmune thrombocytopenic purpura treated with danazol] 2000
- Splenic peliosis with spontaneous splenic rupture in a patient with immune thrombocytopenia treated with danazol 1998
- [Autopsy findings of retroperitoneal cystic tumor and peliosis hepatis in lymphangiomyomatosis] 1997
Source provenance
- openalex
- last seen: 2026-05-10T10:41:41.225191+00:00
- pubmed
- last seen: 2026-10-08T21:59:07.256998+00:00
License: CC0
· commercial use OK